This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Jim Cramer's Top Takeaways: Take-Two Interactive, DexCom, Martin Marietta

Cramer is a believer in Take-Two and understands why DexCom shares hit all-time highs today.

Jim Cramer's 'Mad Money' Recap: Cult Stocks Amazon, Netflix Gave Bulls a Boost

There was a lot to like about today's rally, Cramer says.

Jim Cramer's Top Takeaways: Novavax, Cisco, Freshpet, Macy's

Cramer says investors were too hasty in judging Freshpet and he has faith Macy's can solve its problems.

'Mad Money' Lightning Round: Buy Wells Fargo, America's Banker

Cramer is sticking with Taser and Blackstone but he's avoiding Petrobras and Banco Santander.

Jim Cramer's 'Mad Money' Recap: How the Market Got Its Groove Back

The market got what it craved today, Cramer says.

'Mad Money' Lightning Round: Raytheon Is a Buy, Aqua American Is Not Bad

Cramer prefers Celgene to Biogen Idec and Ventas over Medical Properties Trust.

Jim Cramer's Top Takeaways: WisdomTree Investments, Google, Charles River Labs

Cramer says there are so many things to like about Google's reorganization into Alphabet, a company that'll have no ties to China.

Jim Cramer's 'Mad Money' Recap: How to Make Sense of China's Desperate Act

About the only good thing about the yuan's devaluation is it likely puts off any interest rate hike by the Fed, Cramer says.

Jim Cramer's Top Takeaways: Radius Health, Inovio Pharmaceuticals

Cramer says Radius Health offers investors multiple ways to win.

'Mad Money' Lightning Round: Buy, Buy, Buy MGM Resorts

Cramer likes Enterprise Products Partners, says Dave and Busters is in a tough business and thinks Helen of Troy should be higher.

Page 4 of 396
Top Rated Stocks Top Rated Funds Top Rated ETFs